IFNG and graft versus host disease: These findings might be a combined result of differences in the way detecting CMV-specific T cells producing IFN-γ, differences in the CMV seroprevalence, graft source, conditioning regimens, and use of immunosuppressive agents for preventing GvHD between this and other study.